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Pittsburgh School of Medicine, Pittsburgh, PennsylvaniaABSTRACT Pentameric ligand-gated ion channels are targets of general anesthetics. Although the search for discrete anes-
thetic binding sites has achieved some degree of success, little is known regarding how anesthetics work after the events of
binding. Using the crystal structures of the bacterial Gloeobacter violaceus pentameric ligand-gated ion channel (GLIC), which
is sensitive to a variety of general anesthetics, we performed multiple molecular dynamics simulations in the presence and
absence of the general anesthetic isoflurane. Isoflurane bound to several locations within GLIC, including the transmembrane
pocket identified crystallographically, the extracellular (EC) domain, and the interface of the EC and transmembrane domains.
Isoflurane also entered the channel after the pore was dehydrated in one of the simulations. Isoflurane disrupted the quaternary
structure of GLIC, as evidenced in a striking association between the binding and breakage of intersubunit salt bridges in the EC
domain. The pore-lining helix experienced lateral and inward radial tilting motion that contributed to the channel closure. Isoflur-
ane binding introduced strong anticorrelated motions between different subunits of GLIC. The demonstrated structural and
dynamical modulations by isoflurane aid in the understanding of the underlying mechanism of anesthetic inhibition of GLIC
and possibly other homologous pentameric ligand-gated ion channels.INTRODUCTIONNicotinic acetylcholine receptors (nAChRs), serotonin
receptors, glycine receptors, and the g-aminobutyric acid
class A receptors are pentameric ligand-gated ion channels
(pLGICs). They are also putative targets of general anes-
thetics (1,2). Anesthetics inhibit agonist-elicited cation
conductivity in nAChRs and serotonin receptors, but poten-
tiate anion conductivity in g-aminobutyric acid class A and
glycine receptors (1,2). Specific anesthetic binding to these
proteins has been investigated intensively during recent
decades. Multiple binding sites have been identified mainly
through functional mutations of the proteins and anesthetic
photolabeling to the proteins (3–8). Direct interaction and
functional modulation of general anesthetics are evidenced,
but the underlying mechanisms of anesthetic action on these
channel proteins remain unclear.
pLGICs are molecular machines. Each of the five subunits
in a pLGIC has an extracellular (EC) domain and four trans-
membrane domains (TM1–TM4). The intracellular linker for
TM3 and TM4 varies in length, ranging from a few residues
in bacteria to over a hundred residues in eukaryotic pLGICs.
Agonist binding at the orthosteric sites in the EC domains
allosterically activates receptors. Signal transduction upon
agonist binding has been described vividly as a conforma-
tional wave based on studies with nAChRs (9,10). It is
conceivable that if anything, such as anesthetic binding,
modifies normal waving of the agonist-binding signals, it
will alter the channel function. Anesthetic potentiation of
channel activation elicited by agonists occurs via allosteric
action (5), but inhibition may occur either through allostericSubmitted June 12, 2011, and accepted for publication September 19, 2011.
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a channel pore easily explains anesthetic inhibition. Some
experimental and computational data support the channel
occlusion mechanism (11–13). Anesthetics can also act as
negative allosteric modulators (14–17) to stabilize a noncon-
ducting conformation or to increase the rate of channel
desensitization. Binding sites for negative allosteric modula-
tors, including anesthetics, have been found at the EC-TM
interface (18,19), in nonorthosteric sites at the subunit inter-
faces in the EC domain (19,20), and in an intrasubunit pocket
formed by four TM helices (21). Inhibition by ligands
binding other than in pore lumen is allosteric inhibition.
Understanding how binding at a remote site affects channel
behavior remains a great challenge.
The role of electrostatic interactions in modulating
pLGIC gating has been recognized in the past (10,22–24).
Overall clusters of positively and negatively charged resi-
dues, instead of specific amino acids, mediate interactions
between the agonist binding domain and channel region,
and assist the agonist-elicited channel opening. It has been
shown that electrostatic interaction for signal transmitting
is not limited within a subunit. The intersubunit electrostatic
coupling has been found critically important for normal
activation of glycine receptors (25). Disruption of a salt
bridge between adjacent subunits via mutations of charged
residues caused a profound change in channel function
(25). It has not yet been investigated whether anesthetics
affect the functionally imperative electrostatic interactions
that will further affect channel function.
To fill the knowledge gap between anesthetic binding and
channel inhibition or potentiation, high-resolution structural
information of proteins in various functional states is highly
desirable. For a long time, the model of the Torpedo nAChRdoi: 10.1016/j.bpj.2011.09.026
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the only structural reference for pLGICs. Recent crystal
structures of the bacterial pLGICs from the Erwinia
chrysanthemi (ELIC) (27) and Gloeobacter violaceus
(GLIC) (28,29) provide valuable structural frames for
understanding homologous mammalian pLGICs. In addition
to their structural homology, GLIC and nAChRs show
similar functional sensitivity to anesthetics. TheGLIC cation
current activated by protons can be inhibited by a number of
anesthetics (30), including isoflurane that is used in this
study. Multiple anesthetic binding sites in GLIC have been
identified experimentally (19) or predicted computationally
(13,19). More recently, the crystal structures of GLIC com-
plexed with anesthetic desflurane or propofol provide valu-
able high-resolution information about the location of
binding sites (21). A series of point mutations and functional
measurements have validated the functional relevance of
anesthetic binding in an intrasubunit pocket formed by
four TM helices (21). The crystal structures of GLIC bound
with or without anesthetics, however, are virtually identical
(21,28), as if anesthetics had no impact on GLIC. The
apparent structural insensitivity to anesthetics may result
from a biased conformational preference under certain crys-
tallization conditions. The same concern is also valid for the
anesthetic sites revealed in the crystal structures, in which
only a subset of binding sites were identified likely due to
the low affinity of anesthetics.
In this study, we performed multiple molecular dynamics
(MD) simulations onGLIC in the absence andpresenceof iso-
flurane. There are several advantages for choosing isoflurane
for the study. First, it has demonstrated a functional relevance
by inhibiting theGLIC ion current at a low concentration (30).
Second, it differs byonly one atom fromdesflurane,which has
resolved binding sites in the GLIC crystal structure (21). The
site for desflurane is a reliable reference for isoflurane. Third,
the isofluraneparameterization, essential forMDsimulations,
has been completed (31). Our simulations demonstrated that
isoflurane binds to multiple locations in GLIC, including
the pore lumen. Isoflurane located between two adjacent
subunits could disturb intersubunit salt bridges, either directly
or allosterically, which caused profound quaternary structural
and dynamics changes in GLIC. Insights into isoflurane
modulation on the structure and dynamics of GLIC revealed
in this study may have a general implication in anesthetic
action on other pLGICs.METHODS
System preparation
Three systems were generated with the same preparation except isoflur-
ane binding status: the control system containing no isoflurane; system X
containing isoflurane at positions suggested by the x-ray structure of the
GLIC-desflurane complex (21); and system Y containing isoflurane at
computationally predicted sites. Details of isoflurane positions are shown
in Fig. 1. For each system, the published crystal structure of GLIC (PDBBiophysical Journal 101(8) 1905–1912code: 3EAM) (28) was inserted into an equilibrated binary mixture of
bacterial lipids (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine/
1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(10-rac-glycerol) in the ratio
of 3:1) in a hexagonal prism, solvated, and ionized with VMD plugins
(32). In an attempt to simulate an open channel, GLIC was set in
a protonated state (33). The predicted pKa values for some titratable resi-
dues of GLIC (28) were used in the simulations. For residues without
published values, we calculated their pKa values at a pH of 4.6 using
PROPKA 2.0 (34,35). We also calculated a probability of protonation
for each residue and determined how many of the equivalent residues
in the five subunits should be protonated at the beginning of a simulation.
Details of protonation for residues in each subunit are provided in Table
S1, in the Supporting Material. The control system contains one GLIC,
167 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine, 54 1-palmi-
toyl-2-oleoyl-sn-glycero-3-phospho-(10-rac-glycerol), 48 Naþ, 21 Cl,
and 24,486 TIP3 water molecules.MD simulations
NAMD2.7b1 (36) and CHARMM-27 force field (37) were used for all simu-
lations reported in this study. Each system was initially energy minimized
with a fixed GLIC backbone for 10,000 steps and with no restraints for
another 10,000 steps. The system was warmed from 0 to 310 K over 62 ps
with 1 fs/step and 1 kcal/mol/A˚2 backbone restraints on GLIC, which were
gradually reduced and then removed after 600 ps of simulation. The equili-
brated systems were simulated with a time step of 2 fs at a constant 1 atm
of pressure. Langevin damping value was set to 10 ps1 for the first 2 ns of
simulation and reduced to 1 ps1 for the following 100 ns of simulation.
Particle mesh Ewald was used for long-range electrostatic interactions and
a 12-A˚ cutoff was used for nonbonded interactions. Nonbonded interactions
were evaluated at every step and full electrostatic interactions at every other
step. The systems were simulated with periodic boundary conditions as
hexagonal prisms thatwere ~130 A˚ in thedimension parallel to themembrane
normal, and 104 A˚ between two parallel sides of the hexagon.We performed
two sets of production simulations for the control system (namely, cMD1 and
cMD2), two sets for each isoflurane system (system X: xMD1 and xMD2;
system Y: yMD1 and yMD2). Each simulation lasted for ~102 ns.Anesthetic binding positions
The geometry and parameters of R- or S-isoflurane were used as published
(31). In system X, S-isoflurane was manually placed in the S-desflurane
site revealed in the crystal structure of the desflurane-GLIC complex (21).
Note that isoflurane differs from desflurane by only one atom. Each subunit
contained one isoflurane molecule and there were a total of five isoflurane
molecules in system X. In system Y, putative isoflurane binding sites were
identified initially through docking and preliminary (~16 ns) MD simula-
tions. Only those isoflurane molecules that showed minimal displacements
in the preliminary MD simulations were included in the production MD
simulations. Isoflurane docking results were compiled from 500 runs using
the Lamarckian genetic algorithm implemented in AutoDock 4.0 (38). A
population size of 300, a maximum of 27,000 generations, and maximum
of 15 million energy evaluations were used. For each isoflurane enantiomer,
15 of the most populated and lowest energy, nonoverlapping poses were
selected for the preliminary 16-ns MD simulations. A total of 10 isoflurane
molecules (five sites for each enantiomer) with the lowest displacements
were selected for the production NPT MD simulations. Only the results
from the production simulation are reported in this manuscript.Gaussian network model and principal
component analysis
To elucidate how anesthetics affect GLIC dynamics, we calculated the
mean squared fluctuation (MSF) of GLIC using the Gaussian network
Isoflurane Modulation of GLIC 1907model (GNM) (39,40). The three slowest modes of the GNM were used to
capture low frequency motions that may be important to the protein func-
tion. We also performed principal component analysis (PCA) (41,42) of
trajectories from our MD simulations. For each system, GLIC structural
snapshots with a 20-ps interval were taken and a total of 5100 structures
were used for each PCA. Principal component (PC) calculations were based
on the Ca coordinates of GLIC. Visualization of the directions and extents
of the principal motions of GLIC Ca atoms was done on VMD (32) and the
NMWiz plugin (43). Each cross correlation map was generated based on all
5100 PCs of each simulation set.FIGURE 1 Isoflurane binding sites in system X and system Y at the
beginning and end of each simulation. (a and b) are top views of systems
X and Y at the beginning of each simulation, respectively. (c and e) and
(d and f) are top and side views at the end of each simulation for systems
X and Y, respectively. Subunit labels (gray letters) and colors are consistent
throughout all figures in the manuscript. Isoflurane molecules are colored
according to their final binding sites: yellow for those in the intersubunit
sites in the TM domain; green for those in intrasubunit sites in the TM
domain; red for those at or close to the EC/TM interface; purple for the
one inside the pore; and orange for those in the EC domain.RESULTS AND DISCUSSION
Anesthetic binding sites
Fig. 1 summarizes the isoflurane locations in GLIC before
and after over 100-ns MD simulations. In system X, isoflur-
ane was initially in an intrasubunit pocket at the top of the
TM helices, where desflurane was found in the crystal struc-
ture of the GLIC (21). The intravenous anesthetic propofol,
which has a very different molecular structure from desflur-
ane, was also found nearby the pocket in the cocrystal of
GLIC and propofol (21). With only a one-atom difference
between desflurane and isoflurane, it is reasonable to assume
that isoflurane shares the same binding site as desflurane.
Indeed, four of five isoflurane molecules remained close
to their initial sites for the duration of the simulation. One
isoflurane molecule, named isof-1, moved toward the EC
domain early in the simulation and resided in an intersubunit
pocket in the TM domain at the end of the simulation
(Fig. 1, c and e), suggesting the existence of additional anes-
thetic binding sites that were not captured by the crystal
structure. In the simulation of xMD2, isof-1, along with
another isoflurane molecule, also moved out of their binding
pocket (Fig. S1). Volatile general anesthetics, such as iso-
flurane and desflurane, are low affinity drugs and may
have multiple binding modes. Some of the binding sites
are probably not observable under certain crystallization
conditions. Thus, it is necessary to have various approaches
to identify other plausible anesthetic binding sites.
In system Y, seven isoflurane molecules are bound with
GLIC over the 100-ns simulation. Two (colored yellow in
Fig. 1 b) occupied intersubunit pockets that are homologous
to the final location of isof-1 in system X; two (colored red
in Fig. 1 b) were located at intrasubunit sites on the EC side
of the EC/TM interface. The binding pattern for these four
molecules remained in another independent simulation
(yMD2) for system Y (Fig. S1), suggesting that the pockets
at these two locations are favorable for isoflurane. It is worth
mentioning that both locations were also identified for halo-
thane binding in our previous experiments on GLIC using
point mutations and fluorescence quenching (19). Halothane
was found in proximity to W160 in one location and to
N200 in the other location (19). The remaining three isoflur-
ane molecules began the simulation in the EC domain. One
(colored purple in Fig. 1 b) migrated from the interface
between two subunits into the pore after ~70 ns in the firstsimulation, but stayed in the EC domain in yMD2
(Fig. S1). The other two isoflurane molecules (colored
orange in Fig. 1 b) showed a distinct difference: the one
within the subunit remained in the pocket in both runs of
simulations, but another behind loop C of subunit B showed
a larger displacement in the first simulation (Fig. 1) and
moved into bulk water at a late stage of the second simula-
tion (Fig. S1). The homologous site was suggested for halo-
thane binding in the previous MD simulations on a4b2 and
a7 nAChRs (44–46) and [3H]azietomidate photolabeling at
the a-g interface of Torpedo nAChR (6).Biophysical Journal 101(8) 1905–1912
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Although there is presently no experimental evidence of iso-
flurane binding to the GLIC pore lumen, one of our simula-
tions (yMD1) in this study and a previous simulation (13)
indicate a possibility that isoflurane could go into the
pore. Interestingly, we found that isoflurane entered the
pore after the pore was no longer permeable to water. The
hydrophobic region of the pore, involving residues from
I240 (160) to I233 (90), was dehydrated after ~20 ns of simu-
lation (Fig. S2). But this particular isoflurane molecule was
not near the extracellular pore entrance until ~70 ns after the
simulation began (Fig. S3). Once it moved close to I240, its
trifluoromethyl group approached I240. It took only 0.4 ns
for this isoflurane molecule to pass the hydrophobic ring
of five I240 residues. This isoflurane molecule was then
trapped between I240 (160) and I233 (90) for the rest of
the simulation. The location of isoflurane inside the pore
is consistent with the earlier observation that isoflurane
had the most probable contact with A237 (130) in the
GLIC pore (13).
It is striking to see that isoflurane was able to pass the
channel hydrophobic gate even when the gate was closed
for water. Most general anesthetics are amphipathic. Their
lipophilic groups, such as the trifluoromethyl group in iso-
flurane, could mediate close contact with pore-lining hydro-
phobic residues. If these residues are as flexible as I240 of
GLIC, drug molecules may have an opportunity to pass
the hydrophobic gate even though the pore size is not large
enough for water passage. A recent x-ray study of GLIC
complexed with bromo-lidocaine (47), a positively charged
local anesthetic, suggested that bromo-lidocaine bound to
the pore region. General anesthetics have a wide range of
structures and pharmacological properties. We need to
collect more experimental data to define the importance of
the pore occlusion mechanism in functional inhibition of
GLIC and other pLGICs.FIGURE 2 Stacked bar graphs representing the probability of the salt
bridge occurrence between residues of loop C in the principal subunit
and residues in the adjacent complementary subunit over the course of
each simulation: (a) control system, (b) system X, and (c) system Y.
Subunits for salt bridges at the interface are labeled accordingly. Number
of simultaneous salt bridges in a single frame is indicated by single hash
marks, a single salt bridge; double hash marks, two salt bridges; solid
bar, three salt bridges. Salt bridges were examined in frames collected every
20 ps using the saltbr plugin of VMD (32). Salt bridges were considered as
formed if the distance between the center of mass of the oxygen atoms in
the acidic side chain and center of mass of the nitrogen atoms in the basic
side chain was <4 A˚.Isoflurane binding weakened the quaternary
structure of GLIC
Salt bridges play a critical role not only in stabilizing protein
structures, but also in protein functions (48). It was evi-
denced that salt bridges in Cys-loop receptors were involved
in the agonist elicited channel gating process (10,23,49). In
GLIC, four residues in loop C (E177, D178, R179, and
E181) were found to form intersubunit salt bridges. These
residues contacted residues on the complementary subunit
(R62, D91, R105, and K148) and formed salt bridges over
the course of simulations (Fig. S4). To determine whether
the presence of isoflurane affects formation of these salt
bridges, we counted the number of salt bridges in frames
collected every 20 ps and examined the entire simulation
period for each system. The percentage of frames containing
intersubunit salt bridges in all the examined frames wasBiophysical Journal 101(8) 1905–1912calculated for every intersubunit interface in all three
systems. The results are summarized in Fig. 2 and Fig S5.
For the control system (Fig. 2 a), every subunit interface
of GLIC had at least one salt bridge for over 80% of the
simulation. Two or three salt bridges existed simultaneously
in some of the interfaces. Compared to the isoflurane
systems, the control system had a relatively even distribu-
tion of salt bridges among five intersubunit interfaces.
In xMD1 of system X (Fig. 2 b), the salt bridges
decreased dramatically at the interface of subunits B and
C, whereas there was an obvious increase of salt bridge
formation at the adjacent interface of subunits B and A.
All these changes in salt bridges affected the quaternary
structure of GLIC, as reflected in Fig. 1 c. Isof-1 seemed
to be responsible for these changes. This isoflurane mole-
cule was initially in a TM pocket of subunit B, and later
migrated into an interfacial pocket between subunits B
and C. isof-1 was the only one among five isoflurane mole-
cules in xMD1 that moved from the intrasubunit pocket to
being at the intersubunit interface. Apparently such a move-
ment allosterically destabilized the salt bridges between
subunits B and C in the EC domain. In xMD2, more subunits
were involved in losing interfacial salt bridges due to an
additional isoflurane molecule that moved out from the orig-
inal binding site.
Similar disruptions by interfacial isoflurane were also
observed in system Y. Significantly lower occurrence of
salt bridges at the interface of subunits A and B (Fig. 2 c)
could be ascribed to isoflurane movement at the same inter-
face. The relocation of isoflurane from the interface of
subunits D and E to the pore also perturbed the formation
of salt bridges. Interestingly, when this isoflurane stayed
steadily in the EC domain in the second set of simulation
(yMD2), the occurrence of salt bridges went back to normal
(Fig. S5 c), indicating that a lower occurrence of salt bridges
Isoflurane Modulation of GLIC 1909in Fig. 2 c was indeed caused by disruptions of isoflurane
movement. As also observed in system X, suppression of
salt bridge formation at one interface was accompanied by
promotion of salt bridges in the neighboring interface. The
formation and disruption of these salt bridges were often
accompanied by narrowed and widened intersubunit gaps
that altered the quaternary structure and dynamics of GLIC.TM2 tilting motion
It is evidenced that isoflurane disrupted the quaternary struc-
ture in the EC domain of GLIC, but what about the TM
domain? Orientations of TM2 helices shape the pore geom-
etry and consequently affect the ion-conducting status of
a channel. We characterized the orientation of each TM2
helix using the lateral tilting angle (d) and radial tilting
angle (q) as shown in Fig. S6 and defined previously (50).
Trajectories of q and d for each TM2 helix in the control
system and isoflurane systems over the course of the first
set of simulations are illustrated in Fig. 3. The data for the
repeated simulations are shown in Fig. S7. Compared to
the starting orientation of five TM2 helices in GLIC that
show a funnel-shaped pore opening with the most restricting
part at the intracellular entry of the channel, the EC ends of
TM2 helices in all systems had inward movement, as evi-
denced in smaller, or negative, q values at the end of the
simulations. Lateral tilting angles of TM2 also deviated
from the initial structure. Degrees of deviation varied among
five subunits in a given system. We calculated tilt angles of
TMhelices averaged over the first and last 5 ns of simulations
for each individual system and summarized the data in
Table S2 and Table S3. Several subunits in system Y show
profound clockwise lateral tilting of TM helices (Fig. 3 c
and Fig. S7 c), but the averaged tilting angles among all
subunits in all simulations are not statistically different
from those for the simulations of the control system.
The impact of the TM2 helix tilting on the channel
opening became obvious when the structure of GLIC was
compared with a closed-channel structure of a homologous
protein, ELIC (27). The crystal structure of GLIC represents
a more open channel, which has the EC end of TM2 tiltedradially away from the channel axis (28) with q of 6.5,
but a fairly small lateral tilting (d ¼ 0.7). The crystal struc-
ture of ELIC (27), on the other hand, shows q and d values
of 3.5 and 7.9, respectively. Clearly, TM2 in ELIC has
a clockwise lateral tilting in addition to inward radial move-
ment. In simulations, however, the perfect symmetry among
five subunits in the crystal structures was not sustained.
TM2 helices in different subunits experienced different
degrees of tilting at a given time point. Moreover, it seems
that TM2 tilting in one or two subunits is sufficient to alter
channel permeability to water (Fig. S2). The widest range of
lateral tilting motion experienced by subunit B in both
system X and system Y was concurrent with the most severe
destruction of intersubunit salt bridges (Fig. 2, b and c), indi-
cating that isoflurane disruption of intersubunit salt bridges
may promote the clockwise lateral tilting of the TM2
helices.Interplay between protein dynamics
and isoflurane binding
Fig. 4 shows the MSF derived from the three slowest modes
of GNM analysis for all three GLIC systems. The data
convey at least two important messages. First, the isoflurane
binding sites are almost exclusively restricted to residues
near global hinge regions of GLIC, the majority of which
are located in the EC/TM interface, areas of MSF minima.
Those anesthetics placed in highly mobile regions at the
beginning of the simulations were not retained there and
quickly migrated into bulk water. Hinge regions often play
critical roles in protein motion that are relevant to protein
function (51). Anesthetic occupancy in these hinge regions,
especially at or near the EC/TM interface, may trigger
changes in global protein motions that could affect channel
function. Second, the overall dynamics of GLIC changed
upon isoflurane binding. In system X, there was a marked
increase in dynamics of the EC domain in subunits B and
C, where isof-1 bound to the intersubunit pocket in the
TM domain (see regions marked with yellow diamond
symbols in Fig. 4, B and C). The EC domains of the neigh-
boring subunits, however, experienced overall decreasedFIGURE 3 Polar plots of radial (q) and lateral
(d) tilt angles of the TM2 helices for (a) control;
(b) system X; and (c) system Y. The q angle defines
the inclination of the principal axis of a TM2 helix
with respect to the direction of the channel
symmetry axis. The d angle measures the orienta-
tion of the principal axis of a TM2 helix projected
onto a lateral plane that is perpendicular to the
radial plane. Every 25-ns simulation trajectory is
colored differently in a time order of black, red,
green, blue, and magenta (last 2 ns). The averaged
lateral angels for the first and last 5-ns simulations
are marked by black ticks. The principal axis of
each TM2 helix was calculated based on coordi-
nates of backbone atoms of residues E222–I240.
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FIGURE 4 Mean squared fluctuation of the control system (black),
system X (purple), and system Y (green) based on three slowest modes
of GNM analysis (39,40). Structures after 102-ns simulations were used
for GNM analysis. Each residue of GLIC within 3.5 A˚ of isoflurane for
>30 ns in the last 40-ns simulation is marked with a diamond (system X)
or a circle (system Y) that are colored the same as isoflurane molecules
at each equivalent site shown in Fig. 1. Gray triangles indicate initial iso-
flurane positions where isoflurane migrated away from the protein during
the simulations. The GLIC secondary structure is highlighted at the top
of the figure.
1910 Willenbring et al.dynamical motions compared to the control system. A
similar trend was also observed in system Y. A substantial
number of residues in subunits C and D interacted with iso-
flurane bound to the intersubunit pocket, as highlighted by
the yellow circles in Fig. 4, C and D. The EC domains of
these two subunits also show higher MSF than the control
system. Although it is almost impossible to rule out dynam-
ical contributions of isoflurane bound to other regions, the
increased MSF in the EC domain seems to correlate the
best with isoflurane binding in the intersubunit TM pockets
near the EC-TM interface.
PCA allows us to visualize the direction and extent of the
principal motions of Ca atoms of GLIC in the absence and
presence of isoflurane. The first two eigenvectors account
for over 45% of the total variances observed in the 100 nsBiophysical Journal 101(8) 1905–1912of the simulation trajectories in system X and system Y,
but only ~33% in the control system. Strong subunit repel-
ling motion in EC domains was captured in PC1 of xMD1
(Fig. S8 b) and yMD2 (Fig. S9 c). However, such a motion
was not found in the control simulations. Most TM1, TM3,
and TM4 helices showed counterclockwise tilting motions
in PC1 and PC2, but the TM2 helices exhibited more diverse
motional directions. It appeared that the majority of TM2
helices experienced a clockwise lateral tilting motion, but
some showed profound radial motion (Fig. S8 a and
Fig. S9 c).
The influence of isoflurane on the correlated motions of
GLIC was elucidated in cross correlation maps in Fig. 5.
Without isoflurane (Fig. 5, a), correlated motions were
observed within each subunit, particularly in EC domains.
Anticorrelated motion was not obvious either within or
between subunits in the control system. In contrast, anticor-
related motions between different subunits of GLIC became
much more apparent in system X and system Y (Fig. 5,
b and c). The correlated motions of TM4 and TM3 as well
as TM1 also became stronger than those in the control
system. These major differences between systems with
and without isoflurane were validated in our repeated simu-
lations (Fig. S10).CONCLUSIONS
Three conclusions can be drawn from the current study.
First, isoflurane binds to the pore lumen and other allosteric
sites of GLIC in addition to the sites identified crystallo-
graphically (21). This is consistent with the previous exper-
imental and computational results that multiple anesthetic
binding sites exist in GLIC and other homologous proteins
(4,13,19,45). Second, the isoflurane binding at or near the
EC-TM interface allosterically weakens the quaternary
structure of GLIC, as evidenced by a striking association
between the binding of isoflurane and the disruption of inter-
subunit salt bridges in the EC domain. Third, isoflurane
binding not only alters the GLIC structure, but also the
GLIC motion. Changes in the low frequency motion of
GLIC as captured by GNM analysis, the opposite motionFIGURE 5 Correlated motions of GLIC. (a)
Cross correlation map of GLIC in the control simu-
lation cMD1 reveals residues within a subunit or
between subunits that fluctuate in the same direc-
tion at the same time. (b) Cross correlation map
of GLIC in the xMD1 simulation of the X system.
(c) Cross correlation map of GLIC in the yMD1
simulation of the Y system. Note those motions
that exist in b and c, but not in a: the strong anticor-
related motions in EC domains between different
subunits and the strong correlated motions among
TM4, TM3, and TM1. The color scale runs from
blue (anticorrelated motion) to red (correlated
motion).
Isoflurane Modulation of GLIC 1911directions between adjacent subunits as captured by PCA,
and the strong anticorrelated motions among different
subunits as revealed in cross correlation maps, present
possible dynamics characteristics of anesthetic inhibition
to channel functions. We need more experimental evidence
to further determine key elements that can account for the
underlying mechanism of anesthetic action on GLIC or
other homologous pLGICs.SUPPORTING MATERIAL
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